InvestSMART

Heartland Group Holdings Limited (ASX:HGH)

ALERT: Price-sensitive ASX Announcement for HGH
Current share price for HGH : $1.030 0.09 (9.57%)+
Announcement
Release
23 Oct 2025 8:02AM
Price at Release
$0.940
Full Release
download
Summary
Heartland Group Holdings Limited (HGH) provided a trading update for Q1 of FY2026, ending 30 June 2026. The company reported improved profitability and return on equity (ROE) while expanding its net interest margin (NIM). Heartland Bank's Motor Finance portfolio showed consistent asset quality improvements, and despite challenging business conditions in New Zealand, non-performing loans (NPLs) are expected to improve in Q2. The realization of non-strategic assets (NSAs) exceeded quarterly estimates, indicating strong momentum in asset management. Heartland's key financial metrics, such as net operating income (NOI), operating expenses (OPEX), and impairment expenses, were detailed across its New Zealand and Australian banking operations, showcasing a stable financial performance.
Key Points
  • Heartland reported solid performance for Q1 FY2026, improving profitability and ROE.
  • Net interest margin (NIM) continued to expand.
  • Motor Finance showed consistent asset quality improvements.
  • Challenging NZ business conditions led to increased Business Finance NPLs, expected to improve in Q2 FY2026.
  • Strong progress in realization of non-strategic assets (NSAs), surpassing quarterly estimates.
  • Key metrics reported include NOI, OPEX, and impairment expenses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.